OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease
Ziyan Pan, Moutaz Derbala, Khalid Al‐Naamani, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101512-101512
Open Access | Times Cited: 20
Ziyan Pan, Moutaz Derbala, Khalid Al‐Naamani, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101512-101512
Open Access | Times Cited: 20
Showing 20 citing articles:
Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence
Shadi Zerehpooshnesfchi, Amedeo Lonardo, Jian-Gao Fan, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Shadi Zerehpooshnesfchi, Amedeo Lonardo, Jian-Gao Fan, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Why MASLD Lags Behind MAFLD: A Critical Analysis of Diagnostic Criteria Evolution in Metabolic Dysfunction-Associated Liver Diseases
Mohamed Alboraie, Amna Subhan Butt, Alejandro Piscoya, et al.
Medical Science Monitor (2024) Vol. 30
Closed Access | Times Cited: 6
Mohamed Alboraie, Amna Subhan Butt, Alejandro Piscoya, et al.
Medical Science Monitor (2024) Vol. 30
Closed Access | Times Cited: 6
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD
Mingqian Jiang, Ziyan Pan, Jacob George, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1731-1739
Closed Access | Times Cited: 4
Mingqian Jiang, Ziyan Pan, Jacob George, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1731-1739
Closed Access | Times Cited: 4
The MAFLD definition identifies three homogenous groups of patients
Ziyan Pan, Yusuf Yılmaz, Said A. Al‐Busafi, et al.
Liver International (2024)
Open Access | Times Cited: 4
Ziyan Pan, Yusuf Yılmaz, Said A. Al‐Busafi, et al.
Liver International (2024)
Open Access | Times Cited: 4
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Maito Suoh, Saeed Esmaili, Mohammed Eslam, et al.
Hepatology International (2024)
Open Access | Times Cited: 4
Maito Suoh, Saeed Esmaili, Mohammed Eslam, et al.
Hepatology International (2024)
Open Access | Times Cited: 4
Energy metabolism: an emerging therapeutic frontier in liver fibrosis
Iram Irshad, Saleh A. Alqahtani, Kenichi Ikejima, et al.
Annals of Hepatology (2025), pp. 101896-101896
Open Access
Iram Irshad, Saleh A. Alqahtani, Kenichi Ikejima, et al.
Annals of Hepatology (2025), pp. 101896-101896
Open Access
Comment on “MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease”
Ying Ma, Na Lv, FangBai
Annals of Hepatology (2025), pp. 101909-101909
Open Access
Ying Ma, Na Lv, FangBai
Annals of Hepatology (2025), pp. 101909-101909
Open Access
Metabolic dysfunction and Kidney Disease Risk in Individuals with MAFLD
Ziyan Pan, Mohammed Eslam
Annals of Hepatology (2025), pp. 101910-101910
Open Access
Ziyan Pan, Mohammed Eslam
Annals of Hepatology (2025), pp. 101910-101910
Open Access
Nephrological, Pulmonary, and Dermatological Complications in the Context of MAFLD/NAFLD: A Narrative Review
Vlad Pădureanu, Dalia Dop, Lucrețiu Radu, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 272-272
Open Access
Vlad Pădureanu, Dalia Dop, Lucrețiu Radu, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 272-272
Open Access
Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt
Mohamed Mahmoud Elhoseeny, Fatma Rageh, Samar M Rezk, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mohamed Mahmoud Elhoseeny, Fatma Rageh, Samar M Rezk, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Impact of Dietary Sugars and Saturated Fats on Body and Liver Fat in a Healthcare Worker Population
S Vázquez, Ashuin Kammar‐García, Carlos Moctezuma‐Velázquez, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1328-1328
Open Access
S Vázquez, Ashuin Kammar‐García, Carlos Moctezuma‐Velázquez, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1328-1328
Open Access
MAFLD vs. MASLD: a year in review
Mingqian Jiang, Amna Subhan Butt, Ian Homer, et al.
Expert Review of Endocrinology & Metabolism (2025), pp. 1-12
Closed Access
Mingqian Jiang, Amna Subhan Butt, Ian Homer, et al.
Expert Review of Endocrinology & Metabolism (2025), pp. 1-12
Closed Access
Global multi-societies endorsement of the MAFLD definition
Mohamed Alboraie, Tawesak Tanwandee, Xiaoyuan Xu, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 6, pp. 101573-101573
Open Access | Times Cited: 3
Mohamed Alboraie, Tawesak Tanwandee, Xiaoyuan Xu, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 6, pp. 101573-101573
Open Access | Times Cited: 3
Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans
Lucía De la Cruz-Color, José Alfredo Domı́nguez-Rosales, Montserrat Maldonado‐González, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6420-6420
Open Access | Times Cited: 2
Lucía De la Cruz-Color, José Alfredo Domı́nguez-Rosales, Montserrat Maldonado‐González, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6420-6420
Open Access | Times Cited: 2
NAFLD-MASLD-MAFLD continuum: A swinging pendulum?
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101526-101526
Open Access | Times Cited: 1
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101526-101526
Open Access | Times Cited: 1
MAFLD vs. MASLD: Consensus is unlike evidence!
Enas Kamal, Alaa M Mostafa, Yasser Fouad
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101527-101527
Closed Access | Times Cited: 1
Enas Kamal, Alaa M Mostafa, Yasser Fouad
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101527-101527
Closed Access | Times Cited: 1
MAFLD or MASLD: Let the evidence decide again
Ziyan Pan, Mohammed Eslam
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101521-101521
Open Access | Times Cited: 1
Ziyan Pan, Mohammed Eslam
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101521-101521
Open Access | Times Cited: 1
NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease
Sanal Madhusudana Girija, Robert G. Gish, Nahúm Méndez‐Sánchez, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 1
Sanal Madhusudana Girija, Robert G. Gish, Nahúm Méndez‐Sánchez, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 1
Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos‐Molina
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos‐Molina
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access
Bringing evidence to the MAFLD ‐MASLD debate
Ziyan Pan, Mohammed Eslam
Liver International (2024) Vol. 44, Iss. 7, pp. 1740-1741
Closed Access
Ziyan Pan, Mohammed Eslam
Liver International (2024) Vol. 44, Iss. 7, pp. 1740-1741
Closed Access
